1113 related articles for article (PubMed ID: 8819525)
1. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
2. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
Arvanov VL; Liang X; Russo A; Wang RY
Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
Schindler EA; Harvey JA; Aloyo VJ
Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
[TBL] [Abstract][Full Text] [Related]
4. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.
Krebs-Thomson K; Paulus MP; Geyer MA
Neuropsychopharmacology; 1998 May; 18(5):339-51. PubMed ID: 9536447
[TBL] [Abstract][Full Text] [Related]
5. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.
Scruggs JL; Schmidt D; Deutch AY
Neurosci Lett; 2003 Aug; 346(3):137-40. PubMed ID: 12853103
[TBL] [Abstract][Full Text] [Related]
6. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.
Martín-Ruiz R; Puig MV; Celada P; Shapiro DA; Roth BL; Mengod G; Artigas F
J Neurosci; 2001 Dec; 21(24):9856-66. PubMed ID: 11739593
[TBL] [Abstract][Full Text] [Related]
7. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
8. Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist.
Marek GJ; Aghajanian GK
Eur J Pharmacol; 1994 Jul; 259(2):137-41. PubMed ID: 7957607
[TBL] [Abstract][Full Text] [Related]
9. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
10. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
Sanders-Bush E; Burris KD; Knoth K
J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
Pierce PA; Peroutka SJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
[TBL] [Abstract][Full Text] [Related]
14. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release.
Aghajanian GK; Marek GJ
Brain Res; 1999 Apr; 825(1-2):161-71. PubMed ID: 10216183
[TBL] [Abstract][Full Text] [Related]
15. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
[TBL] [Abstract][Full Text] [Related]
16. DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons.
Scruggs JL; Patel S; Bubser M; Deutch AY
J Neurosci; 2000 Dec; 20(23):8846-52. PubMed ID: 11102493
[TBL] [Abstract][Full Text] [Related]
17. Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors.
Gewirtz JC; Marek GJ
Neuropsychopharmacology; 2000 Nov; 23(5):569-76. PubMed ID: 11027922
[TBL] [Abstract][Full Text] [Related]
18. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens.
Goda SA; Piasecka J; Olszewski M; Kasicki S; Hunt MJ
Psychopharmacology (Berl); 2013 Jul; 228(2):271-82. PubMed ID: 23525524
[TBL] [Abstract][Full Text] [Related]
20. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC
Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
